Silent myocardial ischaemia in treated hypertensives with and without left ventricular hypertrophy

Milos M Stojanovic1, Eoin O'Brien, Simon Lyons

  • 1Blood Pressure Unit and ADAPT Centre, Beaumont Hospital, Dublin 9, Ireland.

Blood Pressure Monitoring
|February 27, 2003
PubMed

Insights

Hypertensive patients with left ventricular hypertrophy (LVH) show a significantly higher prevalence of silent ischaemia compared to those without LVH. Ambulatory ECG monitoring can help identify high-risk patients for cardiovascular complications.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Ischaemia Studies

Background:

  • Silent ischaemia increases risk for myocardial infarction and sudden death.
  • Left ventricular hypertrophy (LVH) is common in hypertensive patients.
  • Prevalence of silent ischaemia in hypertensive patients with and without LVH requires examination.

Purpose of the Study:

  • To investigate the prevalence of silent ischaemia in hypertensive patients.
  • To compare silent ischaemia in hypertensive patients with and without LVH.

Main Methods:

  • 24-h ambulatory blood pressure and ECG monitoring used.
  • Included 20 hypertensive patients with LVH and 20 matched controls without LVH.
  • Ischaemic events defined by asymptomatic ST-depression criteria.

Main Results:

  • 13/20 patients with LVH experienced ischaemic events vs. 4/20 without LVH.
  • Median ischaemic events were significantly higher in the LVH group (7 vs. 0).
  • Median total ischaemic area was significantly greater in hypertensive patients with LVH.

Conclusions:

  • Silent ischaemia prevalence is markedly increased in hypertensive patients with LVH.
  • Ambulatory ECG monitoring aids in identifying high-risk hypertensive patients.
  • LVH indicates increased risk for cardiovascular complications and sudden death.
Abstract

Related Concept Videos

Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...